Apiam Animal Health Future Growth
Future criteria checks 0/6
We currently don't have sufficient analyst coverage to forecast growth and revenue for Apiam Animal Health.
Key information
n/a
Earnings growth rate
n/a
EPS growth rate
| Healthcare earnings growth | 19.8% |
| Revenue growth rate | n/a |
| Future return on equity | n/a |
| Analyst coverage | None |
| Last updated | n/a |
Recent future growth updates
Recent updates
Subdued Growth No Barrier To Apiam Animal Health Limited (ASX:AHX) With Shares Advancing 30%
Feb 24
These 4 Measures Indicate That Apiam Animal Health (ASX:AHX) Is Using Debt Extensively
Oct 12Apiam Animal Health (ASX:AHX) Has Announced That Its Dividend Will Be Reduced To A$0.004
Sep 02Apiam Animal Health (ASX:AHX) Has Re-Affirmed Its Dividend Of AU$0.012
Feb 28Here's Why We Think Apiam Animal Health Limited's (ASX:AHX) CEO Compensation Looks Fair for the time being
Nov 18Apiam Animal Health (ASX:AHX) Has Announced A Dividend Of AU$0.012
Sep 15Apiam Animal Health (ASX:AHX) Has Re-Affirmed Its Dividend Of AU$0.012
Sep 01A Look At The Fair Value Of Apiam Animal Health Limited (ASX:AHX)
Jun 10With EPS Growth And More, Apiam Animal Health (ASX:AHX) Is Interesting
Apr 16Only Four Days Left To Cash In On Apiam Animal Health's (ASX:AHX) Dividend
Mar 14Apiam Animal Health Limited's (ASX:AHX) Intrinsic Value Is Potentially 43% Above Its Share Price
Mar 12Should You Or Shouldn't You: A Dividend Analysis on Apiam Animal Health Limited (ASX:AHX)
Feb 25How Is Apiam Animal Health's (ASX:AHX) CEO Compensated?
Feb 08
Should Weakness in Apiam Animal Health Limited's (ASX:AHX) Stock Be Seen As A Sign That Market Will Correct The Share Price Given Decent Financials?
Jan 18Does Apiam Animal Health (ASX:AHX) Have A Healthy Balance Sheet?
Dec 28Apiam Animal Health Limited's (ASX:AHX) Intrinsic Value Is Potentially 91% Above Its Share Price
Dec 11Is Apiam Animal Health Limited (ASX:AHX) The Right Choice For A Smart Dividend Investor?
Nov 24In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Apiam Animal Health has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2023 | 202 | 3 | 11 | 18 | N/A |
| 9/30/2023 | 197 | 2 | 10 | 18 | N/A |
| 6/30/2023 | 192 | 2 | 9 | 17 | N/A |
| 3/31/2023 | 184 | 4 | 10 | 17 | N/A |
| 12/31/2022 | 176 | 6 | 12 | 17 | N/A |
| 9/30/2022 | 166 | 5 | 11 | 16 | N/A |
| 6/30/2022 | 157 | 5 | 11 | 15 | N/A |
| 3/31/2022 | 149 | 4 | 9 | 14 | N/A |
| 12/31/2021 | 140 | 4 | 8 | 13 | N/A |
| 9/30/2021 | 133 | 5 | 9 | 13 | N/A |
| 6/30/2021 | 126 | 5 | 9 | 14 | N/A |
| 3/31/2021 | 125 | 5 | 8 | 12 | N/A |
| 12/31/2020 | 123 | 5 | 8 | 11 | N/A |
| 9/30/2020 | 121 | 5 | 7 | 9 | N/A |
| 6/30/2020 | 118 | 4 | 6 | 8 | N/A |
| 3/31/2020 | 115 | 4 | 4 | 7 | N/A |
| 12/31/2019 | 112 | 3 | 3 | 6 | N/A |
| 9/30/2019 | 112 | 3 | 3 | 5 | N/A |
| 6/30/2019 | 112 | 3 | 2 | 5 | N/A |
| 3/31/2019 | 112 | 3 | 2 | 6 | N/A |
| 12/31/2018 | 112 | 3 | 3 | 7 | N/A |
| 9/30/2018 | 109 | 3 | 4 | 8 | N/A |
| 6/30/2018 | 107 | 3 | 4 | 9 | N/A |
| 3/31/2018 | 105 | 3 | 3 | 7 | N/A |
| 12/31/2017 | 103 | 4 | 2 | 5 | N/A |
| 9/30/2017 | 100 | 4 | N/A | 4 | N/A |
| 6/30/2017 | 98 | 5 | N/A | 2 | N/A |
| 3/31/2017 | 94 | 5 | N/A | 0 | N/A |
| 12/31/2016 | 90 | 5 | N/A | -2 | N/A |
| 9/30/2016 | 72 | 3 | N/A | -1 | N/A |
| 6/30/2016 | 54 | 0 | N/A | -1 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: Insufficient data to determine if AHX's forecast earnings growth is above the savings rate (2.3%).
Earnings vs Market: Insufficient data to determine if AHX's earnings are forecast to grow faster than the Australian market
High Growth Earnings: Insufficient data to determine if AHX's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: Insufficient data to determine if AHX's revenue is forecast to grow faster than the Australian market.
High Growth Revenue: Insufficient data to determine if AHX's revenue is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if AHX's Return on Equity is forecast to be high in 3 years time